The Threat Of COVID-19 Remains In Papua New Guinea. Protect Yourself, Your Family and Your Community

Stay up to date with the latest information on COVID-19 in Papua New Guinea


Members of the public are advised that the National Control Centre (NCC) Call Centre can now be accessed by email.  For all your queries please email to the following address: We will do our best to respond to your email within 24-48 hours. Thank you.



COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April by the World Health Organization (WHO), the European Commission and France in response to this pandemic. Bringing together governments, global health organisations, manufacturers, scientists, private sector, civil society and philanthropy, with the aim of providing innovative and equitable access to COVID-19 diagnostics, treatments and vaccines. The COVAX pillar is focussed on the latter. It is the only truly global solution to this pandemic because it is the only effort to ensure that people in all corners of the world will get access to COVID-19 vaccines once they are available, regardless of their wealth.

Front Liners received AstraZeneca Covid-19 Vaccine. 132,000 Covid-19 AstraZeneca Vaccine arrived in PNG and front liners and government officers were the first to receive the jabs.

Provincial Covid-19 Statistics In PNG

COVID 19 Papua New Guinea Statistics

[covid-widget type="country-card" country="Papua New Guinea"]